Bristol-Myers Squibb
BMY
#198
Rank
$113.68 B
Marketcap
$55.67
Share price
-0.87%
Change (1 day)
17.08%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2026 (TTM): $48.48 Billion USD

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is $48.48 Billion USD. In 2025 the company made a revenue of $48.19 Billion USD a decrease over the revenue in the year 2024 that were of $48.30 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $48.48 B0.6%
2025 $48.19 B-0.22%
2024 $48.30 B7.32%
2023 $45.00 B-2.5%
2022 $46.15 B-0.49%
2021 $46.38 B9.09%
2020 $42.51 B62.62%
2019 $26.14 B15.89%
2018 $22.56 B8.59%
2017 $20.77 B6.94%
2016 $19.42 B17.31%
2015 $16.56 B4.29%
2014 $15.87 B-3.09%
2013 $16.38 B-7.01%
2012 $17.62 B-17.05%
2011 $21.24 B9.03%
2010 $19.48 B16.69%
2009 $16.69 B-18.93%
2008 $20.59 B12.66%
2007 $18.28 B2.06%
2006 $17.91 B-6.73%
2005 $19.20 B9.35%
2004 $17.56 B-16.45%
2003 $21.02 B16.03%
2002 $18.11 B-5.53%
2001 $19.18 B0.56%
2000 $19.07 B-1.54%
1999 $19.37 B5.95%
1998 $18.28 B9.48%
1997 $16.70 B10.86%
1996 $15.06 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
$96.36 B 98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$56.57 B 16.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$63.31 B 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$61.16 B 26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$72.24 B 49.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$37.22 B-23.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$55.46 B 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$9.93 B-79.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$65.76 B 35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$60.43 B 24.66%๐Ÿ‡ฌ๐Ÿ‡ง UK